128 related articles for article (PubMed ID: 7060227)
1. Effects of alkylating agents on the DNA replication of cultured Yoshida sarcoma cells.
van der Steen J; van Wichen BH; Benckhuysen C
Chem Biol Interact; 1982 Mar; 39(2):191-204. PubMed ID: 7060227
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
4. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide-resistant Yoshida ascites tumor cells and their cross resistance to some alkylating agents.
Gerhartz HH; Liss E; Schmidt H
J Cancer Res Clin Oncol; 1979 Jul; 94(3):257-63. PubMed ID: 479265
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
7. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
Valeriote FA; Tolen SJ
Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
[No Abstract] [Full Text] [Related]
8. Repair replication and unscheduled DNA synthesis in mammalian cell lines showing differential sensitivity to alkylating agents.
Fox M; Fox BW
Mutat Res; 1973 Jul; 19(1):119-28. PubMed ID: 4366326
[No Abstract] [Full Text] [Related]
9. Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.
Twentyman PR; Bleehen NM
Br J Cancer; 1975 Apr; 31(4):417-23. PubMed ID: 1156523
[TBL] [Abstract][Full Text] [Related]
10. The effects of nitrogen mustards on the proliferative and Ig synthetic response of human peripheral blood lymphocytes.
Chien MM; Ashman RF
Immunopharmacology; 1986 Oct; 12(2):155-66. PubMed ID: 3771193
[TBL] [Abstract][Full Text] [Related]
11. The effects of bifunctional alkylating agents on DNA synthesis in sensitive and resistant Yoshida cells.
Carr FJ; Fox BW
Mutat Res; 1982 Aug; 95(2-3):441-56. PubMed ID: 7121494
[TBL] [Abstract][Full Text] [Related]
12. Transcription-terminating lesions induced by bifunctional alkylating agents in vitro.
Pieper RO; Futscher BW; Erickson LC
Carcinogenesis; 1989 Jul; 10(7):1307-14. PubMed ID: 2736721
[TBL] [Abstract][Full Text] [Related]
13. Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard.
van Putten LM; Lelieveld P
Eur J Cancer (1965); 1971 Feb; 7(1):11-6. PubMed ID: 5576726
[No Abstract] [Full Text] [Related]
14. Theophylline does not reverse DNA replicon initiation inhibition in human cells resistant to alkylating agent-theophylline killing synergism.
Ducore JM; Rosenstein BS
Chem Biol Interact; 1984 Sep; 51(2):191-200. PubMed ID: 6540627
[TBL] [Abstract][Full Text] [Related]
15. The effect of alkylating agents and other drugs on the accumulation of melphalan by murine L1210 leukaemia cells in vitro.
Martin AD; Beer RW; Bosanquet AG; Gilby ED
Biochem Pharmacol; 1982 Sep; 31(17):2727-32. PubMed ID: 7138568
[TBL] [Abstract][Full Text] [Related]
16. Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence.
Frei E; Ara G; Teicher B; Bunnell C; Richardson P; Wheeler C; Tew K; Elias A
Cancer Chemother Pharmacol; 2000; 45(3):239-46. PubMed ID: 10663642
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of desoxyribonucleic acid (DNA) synthesis and modification of cell multiplication of Yoshida ascites tumor cells by alkylating substances].
Liss E; Reinecke A; Palme G
Arzneimittelforschung; 1969 Jul; 19(7):1137-40. PubMed ID: 5394516
[No Abstract] [Full Text] [Related]
18. Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
Bhide S; Habs M; Reinbold H; Schmähl D
J Cancer Res Clin Oncol; 1979 May; 94(1):63-7. PubMed ID: 468900
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of alkylating agents 1,3-bis(2-chloroethyl)-1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and nitrogen mustard on nuclear RNA synthesis and processing.
Abelson HT; Karlan D; Penman S
Biochim Biophys Acta; 1974 May; 349(3):389-401. PubMed ID: 4407850
[No Abstract] [Full Text] [Related]
20. Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
Holden SA; Teicher BA; Ara G; Herman TS; Coleman CN
J Natl Cancer Inst; 1992 Feb; 84(3):187-93. PubMed ID: 1542129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
